🧪 Retatrutide – 5mg (Research Peptide)
Retatrutide is an experimental synthetic peptide classified as a triple agonist, targeting GLP-1, GIP, and glucagon receptors. It has been investigated in clinical and laboratory research for its potential effects on metabolism, glucose regulation, and energy balance.
Key Research Notes:
🔬 Mechanism of Action – Acts simultaneously on GLP-1, GIP, and glucagon receptors, making it distinct from single-pathway analogs.
🧬 Metabolic Research – Studied for its influence on insulin secretion, glucose metabolism, appetite regulation, and energy expenditure.
⚡ Triple Agonist Profile – Designed to engage multiple metabolic pathways for broader research outcomes.
📚 Scientific Applications – Explored in experimental models related to endocrine signaling, obesity, and metabolic health.
Form: 5mg lyophilized peptide powder per vial – supplied for laboratory research.
Disclaimer:Retatrutide is provided strictly for laboratory and research purposes only. It is not approved for human consumption, medical use, or dietary supplementation. No therapeutic or performance claims are made.